Johanna Huchting

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Molecular Docking

Top Venues

Antiviral chemistry & chemotherapy

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Benedikt Ganter, Martin Zickler, Johanna Huchting, Matthias Winkler, Anna Lüttjohann, Chris Meier, Gülsah Gabriel, Sebastian Beck
T-705-Derived Prodrugs Show High Antiviral Efficacies against a Broad Range of Influenza A Viruses with Synergistic Effects When Combined with Oseltamivir. Pharmaceutics 15 (6) (2023)
Benedikt Ganter, Martin Zickler, Johanna Huchting, Matthias Winkler, Anna Lüttjohann, Chris Meier, Gülsah Gabriel, Sebastian Beck
T-705-Derived Prodrugs Show High Antiviral Efficacies against a Broad Range of Influenza A Viruses with Synergistic Effects When Combined with Oseltamivir. Pharmaceutics 15 (6) (2023)
Ashleigh Shannon, Barbara Selisko, Nhung-Thi-Tuyet Le, Johanna Huchting, Franck Touret, Géraldine Piorkowski, Véronique Fattorini, François P Ferron, Etienne Decroly, Chris Meier, Bruno Coutard, Olve B Peersen, Bruno Canard
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nature communications 11 (1) (2020)
Johanna Huchting
Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections. Antiviral chemistry & chemotherapy 28 (2020)
Johanna Huchting, Evelien Vanderlinden, Matthias Winkler, Hiba Nasser, Lieve Naesens, Chris Meier
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors. Journal of medicinal chemistry 61 (14) (2018)
Johanna Huchting, Matthias Winkler, Hiba Nasser, Chris Meier
Synthesis of T-705-Ribonucleoside and T-705-Ribonucleotide and Studies of Chemical Stability. ChemMedChem 12 (9) (2017)